Search

Your search keyword '"Michael E. Weinblatt"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Michael E. Weinblatt" Remove constraint Author: "Michael E. Weinblatt" Journal the journal of rheumatology Remove constraint Journal: the journal of rheumatology
22 results on '"Michael E. Weinblatt"'

Search Results

2. Dr. Kremer et al reply

3. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease

4. Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR)

5. Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change

6. The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial

7. Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of Patient-reported Outcomes from a Randomized, Double-blind, Placebo-controlled Trial

8. Antimelanoma Differentiation-associated Gene 5 Dermatomyositis

9. Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus–associated Hypophysitis

10. A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis

11. Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid Arthritis

12. Use of the T-SPOT.TB Assay to Detect Latent Tuberculosis Infection Among Rheumatic Disease Patients on Immunosuppressive Therapy

13. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry

14. Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program

15. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate

16. Evaluation of selected rheumatoid arthritis activity scores for office-based assessment

17. Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis

18. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate

19. Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis

20. Rituximab as therapy for refractory polymyositis and dermatomyositis

21. Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study

22. Performance of a rheumatoid arthritis records-based index of severity

Catalog

Books, media, physical & digital resources